🔗 Share this article

This year's Nobel Prize in medical science has been granted for transformative findings that clarify how the immune system targets harmful pathogens while sparing the healthy tissues.

Three renowned scientists—from Japan Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

Their work uncovered specialized "sentinels" within the immune system that eliminate rogue immune cells capable of harming the body.

The findings are now enabling innovative treatments for immune disorders and cancer.

These laureates will divide a prize fund worth 11 million SEK.

Crucial Findings

"Their research has been essential for understanding how the body's defenses operates and the reason we don't all develop severe self-attack conditions," commented the chair of the Nobel Committee.

This team's research explain a core mystery: In what way does the defense system protect us from numerous invaders while leaving our own tissues unharmed?

Our body's protection system employs immune cells that scan for indicators of infection, including pathogens and bacteria it has never encountered.

These defenders employ detectors—known as receptors—that are produced randomly in countless variations.

This provides the defense network the capacity to combat a wide array of invaders, but the randomness of the mechanism unavoidably produces white blood cells that can attack the body.

Protectors of the Body

Scientists previously knew that a portion of these harmful white blood cells were eliminated in the thymus—the site where immune cells mature.

The latest award recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the system to neutralize any immune cells that attack the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as type-1 diabetes, MS, and RA.

The Nobel panel stated, "The findings have established a new field of investigation and accelerated the creation of new treatments, for instance for tumors and autoimmune diseases."

In malignancies, regulatory T-cells block the system from attacking the growth, so research are focused on reducing their numbers.

For self-attack disorders, experiments are testing boosting regulatory T-cells so the body is no longer being harmed. A similar approach could also be effective in minimizing the risks of organ transplant rejection.

Innovative Experiments

Prof Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus removed, causing self-attack conditions.

He demonstrated that injecting defense cells from other animals could stop the disease—implying there was a mechanism for blocking defenders from attacking the body.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in mice and people that resulted in the discovery of a genetic factor critical for how regulatory T-cells function.

"Their groundbreaking research has uncovered how the immune system is controlled by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," commented a leading biological science specialist.

"This work is a remarkable example of how fundamental physiological study can have broad implications for human health."